.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
US Army
UBS
Merck
Chinese Patent Office
Julphar
Citi
McKesson
Moodys
Accenture

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009175

« Back to Dashboard
NDA 009175 describes FURADANTIN, which is a drug marketed by Casper Pharma Llc and Procter And Gamble and is included in two NDAs. It is available from two suppliers. Additional details are available on the FURADANTIN profile page.

The generic ingredient in FURADANTIN is nitrofurantoin. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.

Summary for NDA: 009175

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 009175

Ingredient-typeNitrofurans

Suppliers and Packaging for NDA: 009175

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FURADANTIN
nitrofurantoin
SUSPENSION;ORAL 009175 NDA Shionogi Inc. 59630-450 59630-450-08 1 BOTTLE, GLASS in 1 CARTON (59630-450-08) > 230 mL in 1 BOTTLE, GLASS
FURADANTIN
nitrofurantoin
SUSPENSION;ORAL 009175 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-471 66993-471-73 1 BOTTLE, GLASS in 1 CARTON (66993-471-73) > 230 mL in 1 BOTTLE, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength25MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Baxter
Novartis
QuintilesIMS
Merck
McKesson
Federal Trade Commission
Julphar
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot